IMCAS World Congress 2025
Program

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): Co-founder

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
Yes
Please specify date...: approved
and status : 2005

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): INMODE

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
Yes
Please specify date...: ACTIVE
and status : QUANTUM PATENT

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): Inmode

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: Inmode

Objectives: 1. Appropriate case selection for the Quantum 10 in the face
2. When to use Quantum 10 and when to use Facetite
3. Results from a 3-year experience of the author in this technology

Introduction: The introduction of Quantum10RF technology marks a groundbreaking advancement in the field of aesthetic medicine. This innovative device operates using a bipolar radiofrequency (RF) mechanism that delivers ultra-short pulse RF energy beneath the skin or deeper into the fat layer. This approach facilitates the dual benefit of fat coagulation and skin tightening, achieving superior outcomes in rejuvenating the neck and lower third of the face. Quantum10RF represents a paradigm shift in minimally invasive aesthetics, offering unparalleled efficiency, precision, and safety.

Materials / method: This presentation draws from the senior author’s extensive clinical experience, encompassing over 35 cases treated with Quantum10RF over the past two years. These cases will be analyzed to highlight clinical efficiency, procedural approaches, and key insights into optimizing patient outcomes.

Results: Key findings include the development of a practical algorithm for determining when to utilize Quantum10RF versus FaceTite, ensuring tailored treatment for each patient. The presentation will emphasize the safety

Conclusion: Quantum10RF represents a transformative advancement in neck and lower third facial rejuvenation, combining unparalleled safety, efficiency, and precision. Its innovative bipolar RF mechanism, delivering ultra-short pulse energy beneath the skin and into the fat, allows for simultaneous fat coagulation and skin tightening, producing remarkable aesthetic outcomes. The integration of techniques such as the Bilayer Sculpting Technique ensures comprehensive, tailored treatments that enhance both contour and skin quality. With a proven safety profile and versatility, Quantum10RF is a game-changer.

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): INMODE

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): INMODE

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): INMODE

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: INMODE

Objectives: Bipolar radiofrequency (RF) technology has undergone significant advancements, introducing groundbreaking upgrades that revolutionize its applications in the aesthetic and medical fields. The latest developments enable a single probe, the bipolar RF 10-piece, to be used effectively for both fat coagulation and skin tightening, as well as for achieving superior results in fat reduction and treatment of various pathologies. In addition to these advancements, enhanced safety features and performance optimizations have been integrated into the technology, offering users improved precision.

Introduction: The field of bipolar RF technology has seen remarkable progress, driven by the integration of new technologies and insights. These advancements have enabled the creation of a versatile single-probe bipolar RF 10-piece system that excels in both fat coagulation and skin tightening. This upgraded device now offers clinicians and practitioners enhanced capabilities in addressing a range of aesthetic and therapeutic concerns with improved safety and efficiency. Among these innovations, the latest updates to the Morpheus system stand out, offering optimized results in RF-based fractional treatment.

Materials / method: The session is a live 20-minute panel discussion featuring some of the world’s foremost authorities on bipolar RF technology. These experts will share their clinical experiences, focusing on the practical application of the updated technology and the benefits it offers. Audience interaction is encouraged through the use of a QR code, allowing attendees to submit questions in real-time and engage directly with the panel.

Results: Panelists will discuss their experiences with the upgraded bipolar RF technology, emphasizing its versatile application in both fat coagulation and skin tightening, along with its enhanced safety features and optimized performance. Real-world outcomes, challenges, and practical tips will be shared to guide practitioners in achieving optimal results.

Conclusion: This session promises to be an invaluable platform for specialists and users of bipolar RF technology. It provides an opportunity for attendees to gain insights from leading experts, address pressing questions, and enhance their understanding of how to optimize outcomes with the latest advancements in bipolar RF fractional and internal treatments. The event underscores the potential of these upgrades to redefine the standards of care and innovation in the field.

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): INMODE

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): INMODE

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: INMODE

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): Co-founder

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
Yes
Please specify date...: approved
and status : 2005

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): INMODE

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
Yes
Please specify date...: ACTIVE
and status : QUANTUM RF PATENT

This work was not supported by any direct or non direct funding. It is under the author's own responsability